title: Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells.
abstract: Proliferation of normal and malignant prostate epithelium is regulated by androgen stimulation via both the androgen receptor (AR)-positive stromal and epithelial cells. However, it is not known how AR expression is regulated in human prostate cells. We report that treatment of normal human prostate stromal cells (PrSCs) with type I IFN (alpha or beta), but not type II IFN (gamma), resulted in increased levels of AR protein. The maximal increase in AR protein levels was dependent on the dose and the duration of the IFN-alpha treatment. We found that the increase in AR protein levels was independent of de novo transcription and protein synthesis. Interestingly, the IFN-alpha treatment of PrSCs resulted in considerable nuclear accumulation of AR, stimulation of AR-mediated transcription of reporter genes, and retardation of cell proliferation. Furthermore, treatment of normal human prostate epithelial cells with IFNs (alpha, beta or gamma) also resulted in increased levels of AR protein. Together, our observations identify the androgen receptor as an IFN-regulated protein in normal human prostate stromal and epithelial cells and predict that IFN-induced levels of AR in prostate cells contribute to the regulation of androgen signaling.
authors.affiliation: Department of Urology, Loyola University Chicago, and Edward Hines Jr VA Hospital, Hines, IL 60141, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Basrawala
authors.forename: F
authors.initials: F
authors.lastname: Alimirah
authors.forename: H
authors.initials: H
authors.lastname: Xin
authors.forename: N
authors.initials: N
authors.lastname: Mohideen
authors.forename: S C
authors.initials: SC
authors.lastname: Campbell
authors.forename: R C
authors.initials: RC
authors.lastname: Flanigan
authors.forename: D
authors.initials: D
authors.lastname: Choubey
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D003609:Dactinomycin / Q000494:pharmacology; D004847:Epithelial Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D016899:Interferon-beta / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D008297:Male; D011467:Prostate / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011944:Receptors, Androgen / Q000235:genetics / Q000378:metabolism*; D017154:Stromal Cells / Q000187:drug effects* / Q000378:metabolism
chemical_list: C410798:AR protein, human; D000970:Antineoplastic Agents; D016898:Interferon-alpha; D011500:Protein Synthesis Inhibitors; D011944:Receptors, Androgen; D003609:Dactinomycin; D016899:Interferon-beta; D007371:Interferon-gamma